Ilika Plc · LSE:IKA
Ilika — Q4 2023 Earnings Presentation
24 slides from Ilika's earnings presentation, Jul 13, 2023
Slide 1: Ilika – Annual Results 2022/3
Ilika – Annual Results 2022/3
Slide 2: Disclaimer
Disclaimer The materials being provided to you in connection with this presentation are strictly confidential and intended only for informational purposes and convenient reference. This document has been prepared by Ilika plc (“Ilika”) and is the responsibility of the same and comprises the written
Slide 3: Ilika at a Glance
Ilika at a Glance Specialists in Solid State Batteries (SSBs) ü 2 product lines: ü Stereax miniature cells used primarily to power miniature medical devices and industrial IoT ü Goliath large format cells targeting the automotive industry and cordless consumer appliances ü Developing SSBs for EV use
Slide 4: Seasoned Management Team
Seasoned Management Team Management Team and Board Offer a Wealth of Diversified Experience Across Multiple Industries Graeme Purdy Jason Stewart Keith Jackson Monika Biddulph Jeremy Millard Chief Executive Officer & Co- Chief Financial Officer Chairman Non-Executive Director Non-Executive Director
Slide 5: Ilika Business Model
Ilika Business Model Asset-light licensing model supported by product and process development on production-intent* equipment * “production-intent” relates to pieces of equipment that could be used for the fabrication of solid state batteries at commercialisation-level volumes Company Stereax Goliat
Slide 6: Stereax: Ilika's Unique Miniature Battery
Stereax: Ilika’s Unique Miniature Battery Stereax Technology is Capable of Revolutionising the Medical Implant Industry Reduced surgical intervention: compact architecture offers higher energy density enabling smaller device designs Improved Safety: no toxic fluid leakage possible Higher Power Densi
Slide 7: Stereax: Designed for a Burgeoning Market
Stereax: Designed for a Burgeoning Market Powering the Electroceutical Revolution Demand for Medical Batteries to Being Driven by Innovation in Electroceuticals and Sensors Smart surgical Smart contact Neuromodulation Implanted sensors Smart orthopedics Smart orthodontic instruments lenses Projected
Slide 8: Commercial Demand for Stereax
Commercial Demand for Stereax Selection of companies which have placed orders with Ilika Customer Device Customer Company Name Type of Company Country Intended Application Area Sector Size & AGR SAM* Device SOM * (devices) A Start Up France Cardiac/Heart Rhythm $5.3bn/4% 100K's 10K's B Multinational
Slide 9: Commercial Order Analysis
Commercial Order Analysis Initial commercial orders from a US-centric customer base 21 24 Companies Orders Company Stereax Goliath ESG Finances Outlook 9 Overview
Slide 10: Stereax-Cirtec Partnering
Stereax-Cirtec Partnering Cirtec Medical: an industry-leading vertically-integrated outsource partner for medical devices and components Partnership Benefits to Ilika: Validation: of Stereax product and process Manufacturing: partnership with economy of scale and ability to ramp production Business
Slide 11: Goliath: Ilika's Cutting Edge Solid State EV Battery
Goliath: Ilika’s Cutting Edge Solid State EV Battery Goliath’s Technology is Capable of Revolutionising the EV Industry with High Performance Batteries Further Range: Oxide electrolyte and silicon anode architecture offer higher energy density v LiB and so better range/weight Improved Safety: Solid-
Slide 12: Goliath Market Dynamics
Goliath Market Dynamics Increasing Demand for Electric Vehicles Demand for EVs is Rapidly Increasing as Costs Decrease and Charging Infrastructure Becomes More Available 2,853 (Unit Sales in Millions) RoW 2,278 2,213 2,048 S. Korea and Japan 1,647 1,354 1,434 1,177 North America 879 711 Europe 498 4
Slide 13: Target Market and Other Key Market Drivers
Target Market and Other Key Market Drivers Ilika’s Unique Position to Service a Fast Growing Market Ilika Targets Luxury Performance Market Electrification of Transportation and Net-Zero Initiatives 1,400 Goliath Market • 19 national governments have committed to 1,200 Energy Point ance, attaining n
Slide 14: Solid State Battery Technology
Solid State Battery Technology What Puts Ilika’s Solid-State Battery Technology Ahead of its Competitors 1 Choice of Materials Safety 4 • Goliath uses an oxide electrolyte which is more stable in air • Goliath is much safer than traditional li-ion batteries; No use than alternative chemistries of fl
Slide 15: Solid-State Battery Technology Landscape
Solid-State Battery Technology Landscape Different chemistries are optimal for different applications Technology Sulfide Electrolyte Oxide Electrolyte Lithium Anode Silicon Anode Anode-less + High ionic + Stable in air + Constant cell + Longer cell life + Cheaper than conductivity voltage lithium an
Slide 16: Manufacturing Capabilities
Manufacturing Capabilities Current Production Process and Capabilities Production Process and Capabilities Initial Pilot Manufacturing • Ilika built the first SSB manufacturing facility in the UK • Raised £25m in July 2021 to extend the development programme through manufacturing readiness and inves
Slide 17: Technology Roadmap and Production Scale-Up
Technology Roadmap and Production Scale-Up Solid-State Battery Energy Density Ilika Scale-up Plan and Business Model 2023/5 Highlights 2025/6 Highlights • 2023: Single layer samples with target areal density and power capability • Testing electrode printing at near Giga scale • Deliver data showing
Slide 18: Existing Partnerships for Technology Deployment
Existing Partnerships for Technology Deployment Ilika Has Entered Critical Partnerships to Fast Track Commercialization of Goliath Faraday Battery Challenge Round 5: HISTORY • A 24-month FBC Collaborative R&D programme • Duration: 1 Feb 23 until 31 Jan 25 • Total programme value: £8M/Ilika grant £2.
Slide 19: ESG
ESG ESG is of utmost importance to Ilika and is routinely on the Board agenda We are ahead of reporting requirements through our commitment to ESG in the past 12 months Benchmarking ESG Materiality ESG Policy Internal Target ESG Monitoring against Committee Assessment Statement Setting Framework and
Slide 20: Stakeholder Importance
ESG Ilika performed its first materiality assessment in 2023 as part of our ESG strategy Stakeholder Importance To understand what is most material to our internal and external stakeholders, a materiality assessment was conducted in 2023 • 26 topics, 4 most material, 8 with high importance In 2023 I
Slide 21: Finances
Finances Ilika Plc, audited financial results for the year ending 30 April 2023 Total Income £0.8m (2022: £0.5m) Resulted from grant funding in respect of four ongoing projects. EBITDA loss, excluding share-based payment £7m (2022: £6.4m) Increased operational costs associated with the Stereax manuf
Slide 22: Outlook
Outlook Progress Cirtec relationship through joint marketing, contract completion and technology transfer Mature Goliath technology with partners through defined technical milestones Continue pursuing grant support and commercial revenue through partnering Commercial opportunity continues to build f
Slide 23: Unit 10a The Quadrangle, Abbey Park Industrial Estate, Romsey SO51 9DL Tel: +44 (0)23
Unit 10a The Quadrangle, Abbey Park Industrial Estate, Romsey SO51 9DL Tel: +44 (0)23 8011 1400 www.ilika.com 23
Slide 24: Thank You!
Thank You! If you have any further questions, please don't hesitate to get in touch via Walbrook PR Ltd: • ilika@walbrookpr.com • Tel: +44 20 7933 8780 24